{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:27:51Z","timestamp":1790638071618,"version":"4.1.0"},"reference-count":122,"publisher":"Ubiquity Press, Ltd.","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["gh"],"DOI":"10.1016\/j.gheart.2014.08.007","type":"journal-article","created":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T04:16:09Z","timestamp":1414728969000},"page":"297","source":"Crossref","is-referenced-by-count":24,"title":["The Burden of Pulmonary Hypertension in Resource-Limited Settings"],"prefix":"10.5334","volume":"9","author":[{"given":"Suman","family":"Gidwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajith","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","published-online":{"date-parts":[[2014,9,1]]},"reference":[{"key":"10.1016\/j.gheart.2014.08.007_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"issue":"Suppl 25","key":"10.1016\/j.gheart.2014.08.007_bib2","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib3","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1161\/CIRCULATIONAHA.107.727289","article-title":"Pulmonary vascular disease in the developing world","volume":"118","author":"Butrous","year":"2008","journal-title":"Circulation"},{"issue":"Suppl 6","key":"10.1016\/j.gheart.2014.08.007_bib4","doi-asserted-by":"crossref","first-page":"85S","DOI":"10.1378\/chest.09-2816","article-title":"Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective","volume":"137","author":"Elliott","year":"2010","journal-title":"Chest"},{"issue":"Suppl 25","key":"10.1016\/j.gheart.2014.08.007_bib5","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/pr.111.005587","article-title":"The pharmacological treatment of pulmonary arterial hypertension","volume":"64","author":"Frumkin","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.gheart.2014.08.007_bib7","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1378\/chest.10-0476","article-title":"Treating pulmonary vascular disease in the developing world: the single step","volume":"137","author":"Mubarak","year":"2010","journal-title":"Chest"},{"issue":"Suppl 25","key":"10.1016\/j.gheart.2014.08.007_bib8","doi-asserted-by":"crossref","first-page":"D73","DOI":"10.1016\/j.jacc.2013.10.034","article-title":"Treatment goals of pulmonary hypertension","volume":"62","author":"McLaughlin","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival\u00a0in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2014.08.007_bib10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"issue":"Suppl 6","key":"10.1016\/j.gheart.2014.08.007_bib11","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1016\/j.amjcard.2012.06.012","article-title":"Echocardiography in pulmonary arterial hypertension","volume":"110","author":"Forfia","year":"2012","journal-title":"Am J Cardiol"},{"issue":"Suppl 25","key":"10.1016\/j.gheart.2014.08.007_bib12","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.jacc.2013.10.031","article-title":"Updated treatment algorithm of pulmonary arterial hypertension","volume":"62","author":"Gali\u00e8","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib13","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood-2010-04-282095","article-title":"Pulmonary hypertension and NO in sickle cell","volume":"116","author":"Gladwin","year":"2010","journal-title":"Blood"},{"issue":"Suppl 6","key":"10.1016\/j.gheart.2014.08.007_bib14","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1378\/chest.09-2445","article-title":"High-altitude disorders: pulmonary hypertension: pulmonary vascular disease: the global perspective","volume":"137","author":"Pasha","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.gheart.2014.08.007_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.gheart.2012.06.015","article-title":"Waiting to inhale: an exploratory review of conditions that may predispose to pulmonary hypertension and right heart failure in persons exposed to household air pollution in low- and middle-income countries","volume":"7","author":"Bloomfield","year":"2012","journal-title":"Glob Heart"},{"key":"10.1016\/j.gheart.2014.08.007_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrmicro801","article-title":"Schistosomiasis","volume":"2","author":"Chitsulo","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib17","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2014.08.007_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0140-6736(04)16587-2","article-title":"HIV prevalence and trends in sub-Saharan Africa: no decline and large subregional differences","volume":"364","author":"Asamoah-Odei","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2014.08.007_bib19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/0035-9203(67)90125-3","article-title":"Pathological lesions associated with Schistosoma mansoni infection in man","volume":"61","author":"Cheever","year":"1967","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.gheart.2014.08.007_bib20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1073\/pnas.0305064101","article-title":"IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis","volume":"101","author":"Mentink-Kane","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gheart.2014.08.007_bib21","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2353\/ajpath.2010.100063","article-title":"Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling","volume":"177","author":"Graham","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gheart.2014.08.007_bib22","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00436-011-2661-4","article-title":"Inflammatory cytokines IFN-\u03b3, IL-4, IL-13 and TNF-\u03b1 alterations in schistosomiasis: a meta-analysis","volume":"110","author":"Yu","year":"2012","journal-title":"Parasitol Res"},{"key":"10.1016\/j.gheart.2014.08.007_bib23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1471-2334-14-282","article-title":"TGF beta and IL13 in schistosomiasis mansoni associated pulmonary arterial hypertension; a descriptive study with comparative groups","volume":"14","author":"Ferreira Rde","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.gheart.2014.08.007_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1165\/rcmb.2002-0241OC","article-title":"Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation","volume":"29","author":"Chiu","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.gheart.2014.08.007_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4269\/ajtmh.1970.19.305","article-title":"Pathogenesis of schistosomal pulmonary arteritis","volume":"19","author":"Andrade","year":"1970","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.gheart.2014.08.007_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/S0104-42302006000300012","article-title":"Martins Bdo C, Arakaki JS, Souza R. [Clinical characteristics of pulmonary hypertension patients in two reference centers in the city of Sao Paulo]","volume":"52","author":"Lapa","year":"2006","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.gheart.2014.08.007_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/324668","article-title":"Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni","volume":"185","author":"de Jesus","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.gheart.2014.08.007_bib28","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.108.803221","article-title":"Cardiopulmonary manifestations of hepatosplenic schistosomiasis","volume":"119","author":"Lapa","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2014.08.007_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2010.03.065","article-title":"Survival in schistosomiasis-associated pulmonary arterial hypertension","volume":"56","author":"dos Santos Fernandes","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib30","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/eurheartj\/ehs471","article-title":"Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era","volume":"34","author":"Cerrato","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.gheart.2014.08.007_bib31","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/CIRCULATIONAHA.113.004574","article-title":"Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research","volume":"129","author":"Remick","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2014.08.007_bib32","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1097\/QAD.0b013e328362ba67","article-title":"The burden of HIV: insights from the Global Burden of Disease Study 2010","volume":"27","author":"Ortblad","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.gheart.2014.08.007_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.200704-541OC","article-title":"Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era","volume":"177","author":"Sitbon","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1378\/chest.101.2.474","article-title":"Pulmonary hypertension and human immunodeficiency virus infection: two reports and a review of the literature","volume":"101","author":"Polos","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.gheart.2014.08.007_bib35","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bbrc.2005.05.198","article-title":"Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins","volume":"333","author":"Kanmogne","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.gheart.2014.08.007_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/rccm.200601-005OC","article-title":"HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques","volume":"174","author":"Marecki","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.abb.2006.02.020","article-title":"HIV-1 Tat interaction with cyclin T1 represses mannose receptor and the bone morphogenetic protein receptor-2 transcription","volume":"449","author":"Caldwell","year":"2006","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.gheart.2014.08.007_bib38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1189\/jlb.0405194","article-title":"HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells","volume":"79","author":"Caldwell","year":"2006","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.gheart.2014.08.007_bib39","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1161\/ATVBAHA.113.302054","article-title":"Downregulation of bone morphogenetic protein receptor axis during HIV-1 and cocaine-mediated pulmonary smooth muscle hyperplasia: implications for HIV-related pulmonary arterial hypertension","volume":"33","author":"Dalvi","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.gheart.2014.08.007_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/79226","article-title":"Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension","volume":"26","author":"Lane","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.gheart.2014.08.007_bib41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/316947","article-title":"BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension","volume":"68","author":"Machado","year":"2001","journal-title":"Am J Human Genet"},{"key":"10.1016\/j.gheart.2014.08.007_bib42","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1164\/ajrccm.153.4.8616557","article-title":"Primary pulmonary hypertension in HIV infection: an outcome determined by particular HLA class II alleles","volume":"153","author":"Morse","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib43","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1378\/chest.118.4.1133","article-title":"HIV-related pulmonary hypertension: analytic review of 131 cases","volume":"118","author":"Mehta","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.gheart.2014.08.007_bib44","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1164\/rccm.200204-330OC","article-title":"Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"167","author":"Nunes","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1378\/chest.11-3241","article-title":"Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis","volume":"144","author":"Poms","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.gheart.2014.08.007_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QAD.0b013e328331c65e","article-title":"HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era","volume":"24","author":"Degano","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.gheart.2014.08.007_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2046-4053-3-11","article-title":"HHV-8 seroprevalence: a global view","volume":"3","author":"Rohner","year":"2014","journal-title":"Syst Rev"},{"key":"10.1016\/j.gheart.2014.08.007_bib48","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa035115","article-title":"Expression of human herpesvirus 8 in primary pulmonary hypertension","volume":"349","author":"Cool","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib49","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.rmed.2004.07.020","article-title":"Absence of human herpesvirus 8 in lung tissues from Japanese patients with primary pulmonary hypertension","volume":"98","author":"Daibata","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib50","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.200504-546OC","article-title":"Absence of Kaposi's sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension","volume":"172","author":"Henke-Gendo","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjcard.2009.04.034","article-title":"Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease","volume":"104","author":"Dham","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib52","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1005565","article-title":"A\u00a0hemodynamic study of pulmonary hypertension in sickle cell disease","volume":"365","author":"Parent","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib54","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacc.2006.09.038","article-title":"Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease","volume":"49","author":"Sachdev","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib55","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jama.2012.358","article-title":"Mortality in adults with sickle cell disease and pulmonary hypertension","volume":"307","author":"Mehari","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.gheart.2014.08.007_bib56","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ajh.21162","article-title":"Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria","volume":"83","author":"Aliyu","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.gheart.2014.08.007_bib57","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.jacc.2014.01.081","article-title":"Pulmonary hypertension of sickle cell disease beyond classification constraints","volume":"63","author":"Klings","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ajh.20107","article-title":"Vasoactive factors in sickle cell disease: in\u00a0vitro evidence for endothelin-1-mediated vasoconstriction","volume":"76","author":"Ergul","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.gheart.2014.08.007_bib59","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1164\/rccm.201111-2082CI","article-title":"Pulmonary complications of sickle cell disease","volume":"185","author":"Miller","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib60","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.106.624544","article-title":"The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness","volume":"115","author":"Penaloza","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2014.08.007_bib61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/ham.2005.6.147","article-title":"Consensus statement on chronic and subacute high altitude diseases","volume":"6","author":"Le\u00f3n-Velarde","year":"2005","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.gheart.2014.08.007_bib62","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1378\/chest.08-1094","article-title":"Pulmonary pressure and cardiac function in chronic mountain sickness patients","volume":"135","author":"Maignan","year":"2009","journal-title":"Chest"},{"issue":"Suppl 4","key":"10.1016\/j.gheart.2014.08.007_bib63","first-page":"431","article-title":"Chronic mountain sickness: the reaction of physical disorders to chronic hypoxia","volume":"57","author":"Zubieta-Castillo","year":"2006","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.gheart.2014.08.007_bib64","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.RES.0000243584.45145.3f","article-title":"Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms","volume":"99","author":"Stenmark","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.gheart.2014.08.007_bib65","first-page":"39","article-title":"[Changes in pulmonary arterial pressure in healthy subjects on the plain and at high altitudes under exercise load]","volume":"15","author":"Yang","year":"1987","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.gheart.2014.08.007_bib66","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1164\/ajrccm\/145.5.1201","article-title":"Lack of smooth muscle in the small pulmonary arteries of the native Ladakhi. Is the Himalayan highlander adapted?","volume":"145","author":"Gupta","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.gheart.2014.08.007_bib67","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/(SICI)1520-6300(1999)11:3<383::AID-AJHB9>3.0.CO;2-X","article-title":"Effect of developmental and ancestral high altitude exposure on chest morphology and pulmonary function in Andean and European\/North American natives","volume":"11","author":"Brutsaert","year":"1999","journal-title":"Am J Hum Biol"},{"key":"10.1016\/j.gheart.2014.08.007_bib68","doi-asserted-by":"crossref","first-page":"17593","DOI":"10.1073\/pnas.0707462104","article-title":"Higher blood flow and\u00a0circulating NO products offset high-altitude hypoxia among Tibetans","volume":"104","author":"Erzurum","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gheart.2014.08.007_bib69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.resp.2007.05.013","article-title":"Detecting natural selection in high-altitude human populations","volume":"158","author":"Beall","year":"2007","journal-title":"Respir Physiol Neurobiol"},{"issue":"Suppl 1","key":"10.1016\/j.gheart.2014.08.007_bib70","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1073\/pnas.0701985104","article-title":"Two routes to functional adaptation: Tibetan and Andean high-altitude natives","volume":"104","author":"Beall","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 6","key":"10.1016\/j.gheart.2014.08.007_bib71","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1378\/chest.10-0087","article-title":"Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective","volume":"137","author":"Minai","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.gheart.2014.08.007_bib72","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1183\/09031936.00015608","article-title":"Pulmonary hypertension in COPD","volume":"32","author":"Chaouat","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.gheart.2014.08.007_bib73","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ije\/20.3.749","article-title":"Domestic pollution and respiratory illness in a Himalayan village","volume":"20","author":"Norboo","year":"1991","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib74","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(09)61303-9","article-title":"Chronic obstructive pulmonary disease in non-smokers","volume":"374","author":"Salvi","year":"2009","journal-title":"Lancet"},{"issue":"Suppl 25","key":"10.1016\/j.gheart.2014.08.007_bib75","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","article-title":"Pulmonary hypertension in chronic lung diseases","volume":"62","author":"Seeger","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib76","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1378\/chest.103.1.12","article-title":"Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation","volume":"103","author":"Sandoval","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.gheart.2014.08.007_bib77","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-200009000-00004","article-title":"Hut lung: a domestically acquired particulate lung disease","volume":"79","author":"Gold","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.gheart.2014.08.007_bib78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/thx.39.5.337","article-title":"Domestic smoke pollution and chronic bronchitis in a\u00a0rural community of the Hill Region of Nepal","volume":"39","author":"Pandey","year":"1984","journal-title":"Thorax"},{"key":"10.1016\/j.gheart.2014.08.007_bib79","first-page":"471","article-title":"Domestic smoke pollution and respiratory function in rural Nepal","volume":"10","author":"Pandey","year":"1985","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib80","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/eurjhf\/hfr108","article-title":"A\u00a0not-so-rare form of heart failure in urban black Africans: pathways to right heart failure in the Heart of Soweto Study cohort","volume":"13","author":"Stewart","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.gheart.2014.08.007_bib81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mrgentox.2008.10.005","article-title":"Air pollutants, oxidative stress and human health","volume":"674","author":"Yang","year":"2009","journal-title":"Mutat Res"},{"key":"10.1016\/j.gheart.2014.08.007_bib82","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbadis.2004.02.001","article-title":"Air pollutants increase gene expression of the vasoconstrictor endothelin-1 in the lungs","volume":"1689","author":"Thomson","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.gheart.2014.08.007_bib83","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","article-title":"Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2014.08.007_bib84","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ijcard.2012.11.065","article-title":"Worldwide risk factors for heart failure: a systematic review and pooled analysis","volume":"168","author":"Khatibzadeh","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib85","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"issue":"Suppl 6","key":"10.1016\/j.gheart.2014.08.007_bib86","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1378\/chest.09-2861","article-title":"Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective","volume":"137","author":"Adatia","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.gheart.2014.08.007_bib87","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.106.627224","article-title":"Congenital heart disease in the general population: changing prevalence and age distribution","volume":"115","author":"Marelli","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2014.08.007_bib88","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/bmj.2.5099.755","article-title":"The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt","volume":"2","author":"Wood","year":"1958","journal-title":"Br Med J"},{"key":"10.1016\/j.gheart.2014.08.007_bib89","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jsha.2010.04.014","article-title":"Paediatric cardiology programs in countries with limited resources: how to bridge the gap","volume":"22","author":"Sulafa","year":"2010","journal-title":"J\u00a0Saudi Heart Assoc"},{"key":"10.1016\/j.gheart.2014.08.007_bib90","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0735-1097(88)90378-6","article-title":"Prevalence of congenital cardiac anomalies at high altitude","volume":"12","author":"Miao","year":"1988","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib91","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(11)61171-9","article-title":"Rheumatic heart disease","volume":"379","author":"Marijon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2014.08.007_bib92","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4103\/2045-8932.114779","article-title":"Persistent pulmonary artery hypertension in patients undergoing balloon mitral valvotomy","volume":"3","author":"Nair","year":"2013","journal-title":"Pulm Circ"},{"key":"10.1016\/j.gheart.2014.08.007_bib93","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: natural history and the importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2014.08.007_bib94","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09059180.00001713","article-title":"Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?","volume":"22","author":"Seferian","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.gheart.2014.08.007_bib95","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib96","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2014.08.007_bib97","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib98","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib99","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib100","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2014.08.007_bib101","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib102","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A\u00a0comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib103","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib104","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1378\/chest.121.5.1561","article-title":"Transitioning from i.v. epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension","volume":"121","author":"Vachi\u00e9ry","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.gheart.2014.08.007_bib105","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial","volume":"55","author":"McLaughlin","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib106","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.112.124388","article-title":"Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial","volume":"127","author":"Jing","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2014.08.007_bib107","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.11-2212","article-title":"Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and\/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial","volume":"142","author":"Tapson","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.gheart.2014.08.007_bib108","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib109","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1378\/chest.11-0483","article-title":"The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension","volume":"141","author":"Fernandes","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.gheart.2014.08.007_bib110","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1164\/ajrccm.162.5.2004042","article-title":"Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension","volume":"162","author":"Aguilar","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib111","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/rccm.200404-445OC","article-title":"Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"170","author":"Sitbon","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib112","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1183\/09031936.03.00057703","article-title":"Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension","volume":"23","author":"Ghofrani","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.gheart.2014.08.007_bib113","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1183\/09031936.00094808","article-title":"Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension","volume":"33","author":"Degano","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.gheart.2014.08.007_bib114","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4330\/wjc.v6.i6.495","article-title":"Pulmonary arterial hypertension related to human immunodeficiency virus infection: a case series","volume":"6","author":"Araujo","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1016\/j.gheart.2014.08.007_bib115","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2010.08097.x","article-title":"Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies","volume":"149","author":"Barst","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.gheart.2014.08.007_bib116","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2010-09-306167","article-title":"Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity","volume":"118","author":"Machado","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.gheart.2014.08.007_bib117","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1164\/rccm.200208-967OC","article-title":"Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?","volume":"168","author":"Morris","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gheart.2014.08.007_bib118","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","article-title":"Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"issue":"Suppl 6","key":"10.1016\/j.gheart.2014.08.007_bib119","doi-asserted-by":"crossref","first-page":"78S","DOI":"10.1378\/chest.09-2960","article-title":"Pulmonary hypertension in Latin America: pulmonary vascular disease: the global perspective","volume":"137","author":"Lopes","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.gheart.2014.08.007_bib120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1378\/chest.10-2327","article-title":"Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era","volume":"140","author":"Zhang","year":"2011","journal-title":"Chest"},{"issue":"Suppl 6","key":"10.1016\/j.gheart.2014.08.007_bib121","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1378\/chest.09-2813","article-title":"Targeting pulmonary vascular disease to improve global health: pulmonary vascular disease: the global perspective","volume":"137","author":"Rich","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.gheart.2014.08.007_bib122","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.107.733444","article-title":"Low priority of cardiovascular and chronic diseases on the global health agenda: a cause for concern","volume":"116","author":"Fuster","year":"2007","journal-title":"Circulation"}],"container-title":["Global Heart"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211816014026118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211816014026118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2014.08.007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T12:48:35Z","timestamp":1657543715000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/article\/10.1016\/j.gheart.2014.08.007\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":122,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,9,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2014.08.007","relation":{},"ISSN":["2211-8179","2211-8160"],"issn-type":[{"value":"2211-8179","type":"electronic"},{"value":"2211-8160","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}